Immunogenicity and Safety of the Seasonal Flu Vaccine in Elderly and in SOT Recipients

NCT02746783 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

163

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Single dose MUTAGRIP® influenza vaccine
DRUG: Double dose of MUTAGRIP® influenza vaccine

Sponsor

University of Lausanne Hospitals